The Pan-Cancer Analysis Uncovers the Prognostic and Immunotherapeutic Significance of CD19 as an Immune Marker in Tumor.

Lanyi WeiJingjing MengDanfeng XiangQuan-Jun YangYangyun ZhouLingyan XuJunjun ChenYonglong Han

Published in: International journal of general medicine (2024)

The study reveals the potential of CD19 as both a predictive biomarker and a target for different cancer immunotherapies.

Keyphrases